Experience Fenwick Represents Passage Bio in Definitive Merger Agreement with Remix Therapeutics June 24, 2026
Experience Fenwick Represents Dragos in Sale of Majority Stake to Accenture at a $3.25 Billion Valuation June 19, 2026